Kitazawa, Shoko http://orcid.org/0000-0002-4934-6622
Chiyoda, Tatsuyuki http://orcid.org/0000-0002-8214-2242
Nakamura, Kohei http://orcid.org/0000-0002-5162-7132
Sakai, Kensuke http://orcid.org/0000-0002-1406-086X
Yoshihama, Tomoko http://orcid.org/0000-0003-4466-0820
Nishio, Hiroshi http://orcid.org/0000-0002-4938-416X
Kobayashi, Yusuke http://orcid.org/0000-0002-4503-2845
Iwata, Takashi http://orcid.org/0000-0001-7846-9261
Banno, Kouji http://orcid.org/0000-0003-2610-2833
Yamagami, Wataru http://orcid.org/0000-0003-3925-6057
Nishihara, Hiroshi http://orcid.org/0000-0002-5460-8703
Aoki, Daisuke http://orcid.org/0000-0002-9596-8326
Funding for this research was provided by:
Japan Society for the Promotion of Science London (21H03079, 21K16822)
Article History
Received: 26 April 2023
Accepted: 29 July 2023
First Online: 13 August 2023
Declarations
:
: Tatsuyuki Chiyoda reported grants from Takeda Pharmaceutical Company. Daisuke Aoki reported honoraria from Takeda Pharmaceutical Company, Chugai Pharmaceutical Company, AstraZeneca, MSD and Myriad Genetics. The other authors declare no conflicts of interest regarding this study.